Winning and Losing Stocks in the Healthcare Sector for the Week Ending Dec 2nd

Wall St. Watchdog reveals information about winning and losing stocks in the Healthcare (NYSE:XLV) sector for the week ending Dec 2nd, 2011:

Gainers (% price change)

  • Amicus Therapeutics, Inc. (NASDAQ:FOLD): The shares closed at $3.21, up $1.11, or 52.86%, on the week. Its market capitalization is $111.23 million. About the company: Amicus Therapeutics, Inc. is a biopharmaceutical company that develops orally-administered, small molecule drugs to treat human genetic diseases. The drugs, called pharmacological chaperones, are being developed to treat Fabray, Gaucher, and Pompe disease. Get the most recent company news and stock data here >>
  • Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC): The shares closed at $0.73, up $0.21, or 40.38%, on the week. Its market capitalization is $39.59 million. About the company: Cyclacel Pharmaceuticals Inc. discovers and develops small molecule cycle inhibitors for the treatment of cancer and other serious diseases. Get the most recent company news and stock data here >>
  • Progenics Pharmaceuticals Inc. (NASDAQ:PGNX): The shares closed at $7.00, up $1.97, or 39.17%, on the week. Its market capitalization is $236.32 million. About the company: Progenics Pharmaceuticals, Inc. is a biopharmaceutical company. The Company develops and distributes therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Progenics’ principal programs are directed toward supportive care, virology (human immunodeficiency virus and hepatitis C virus infections), and oncology. Get the most recent company news and stock data here >>
  • Inhibitex, Inc. (NASDAQ:INHX): The shares closed at $15.51, up $4.36, or 39.1%, on the week. Its market capitalization is $1.214 billion. About the company: Inhibitex Inc. is a biopharmaceutical company that discovers, develops, and commercializes novel antibody-based products. The Company develops products for the prevention and treatment of serious bacterial and fungal infections in the hospital setting. Get the most recent company news and stock data here >>
  • Athersys, Inc. (NASDAQ:ATHX): The shares closed at $1.66, up $0.44, or 36.07%, on the week. Its market capitalization is $39.01 million. About the company: Athersys Incorporated is a biotechnology company. The Company has developed technologies that will help identify gene and related proteins and create synthetic human chromosomes. Get the most recent company news and stock data here >>

Losers (% price change)

  • DARA BioSciences, Inc (NASDAQ:DARA): The shares closed at $1.02, down $0.4, or 28.17%, on the week. Its market capitalization is $5.57 million. About the company: DARA BioSciences, Inc. is a development stage pharmaceutical company. The Company acquires therapeutic molecules and medical technologies directly or through investment in established companies. DARA focuses on small molecules from late preclinical development through phase 2 clinical trials for neuropathic pain, metabolic diseases, and dermatological disorders. Get the most recent company news and stock data here >>
  • Response Genetics, Inc (NASDAQ:RGDX): The shares closed at $1.05, down $0.4, or 27.59%, on the week. Its market capitalization is $20.52 million. About the company: Response Genetics, Inc. is a biopharmaceutical company that researches and develops pharmacogenomic diagnostic tests. The Company’s products are targeted for potential use in the treatment of cancer. Get the most recent company news and stock data here >>
  • Horizon Pharma, Inc. (NASDAQ:HZNP): The shares closed at $5.06, down $1.75, or 25.7%, on the week. Its market capitalization is $98.82 million. About the company: Horizon Pharma, Inc., is a holding company. The Company, through its subsidiaries, develops and commercializes late-stage biopharmaceutical therapies for the treatment of pain and inflammation. Get the most recent company news and stock data here >>
  • Celsion Corp. (NASDAQ:CLSN): The shares closed at $2.18, down $0.62, or 22.14%, on the week. Its market capitalization is $58.18 million. About the company: Celsion Corporation is a development company specializing in heat based treatments for cancer and other diseases. The Company’s products include a heat activated liposomal form of doxorubicin for the treatment for liver and breast cancers. Get the most recent company news and stock data here >>
  • Accelr8 Technology Corp. (AMEX:AXK): The shares closed at $1.39, down $0.39, or 21.91%, on the week. Its market capitalization is $15.43 million. About the company: Accelr8 Technology Corporation develops diagnostic systems for bacterial infections. Get the most recent company news and stock data here >>

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>